Prognostic factors in IgD myeloma: A study of 21 cases
- 1 November 1984
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 33 (5) , 471-475
- https://doi.org/10.1111/j.1600-0609.1984.tb00727.x
Abstract
A series of 21 patients with IgD myeloma was studied retrospectively, to assess which parameter present at the time of diagnosis was of prognostic importance for survival and whether the clinical staging system of Durie and Salmon had predictive value for the survival time of these patients. Survival time did not appear to be correlated with haemoglobin concentration, thrombocytopenia, initial level of M‐protein, amount of Bence‐Jones proteinuria, hypercalcaemia, serum creatinine level, presence of osteolytic lesions or hepatosplenomegaly. Neither did the staging system of Durie and Salmon predict the survival time. It is concluded that clinical staging is of limited value in the management and prediction of the survival time of IgD myeloma patients.Keywords
This publication has 11 references indexed in Scilit:
- Primary Plasma Cell LeukaemiaActa Haematologica, 1983
- IgD Kappa Plasma Cell Dyscraslas: Extraosseous Manifestations Including Isolated LeptomeningitisAmerican Journal of Clinical Pathology, 1982
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980
- PRETREATMENT TUMOR MASS, CELL-KINETICS, AND PROGNOSIS IN MULTIPLE-MYELOMA1980
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- IgD Multiple MyelomaArchives of internal medicine (1960), 1975
- PART I. ANALYSIS OF PRESENTING FEATURES OF PROGNOSTIC IMPORTANCEBritish Journal of Haematology, 1973
- Younger Age of Presentation and Extraosseous Tumour in IgD MyelomatosisBMJ, 1969
- Plasma cell myeloma with D-myeloma protein (IgD myeloma)The American Journal of Medicine, 1968
- A NEW CLASS OF HUMAN IMMUNOGLOBULINSThe Journal of Experimental Medicine, 1965